May 11, 2023 – Birmingham, AL - Compression Works Inc., the medical device company that developed the Abdominal Aortic and Junctional Tourniquet - Stabilized (AAJT-S), is proud to announce that it will be showcasing their life-saving technology and leading lab training programs at the prestigious Special Operations Medical Association (SOMA) conference. The aim of this event is to educate attendees about AAJT-S's multi-functional benefits.
Compression Works
Newsroom
April 11, 2023 – Birmingham, AL Compression Works, Inc., a medical device company and manufacturer of the Abdominal Aortic & Junctional Tourniquet – Stabilized (AAJT-S), announces the completion of their $2 million seed-growth round and continued strong interest in filling out a board approved over-subscription along with the recent investment by the North Texas Angel Network (NTAN) this past week.
Birmingham AL, March 30, 2023, Compression Works Inc., a medical device company focused on hemorrhage control and pelvic stabilization, announced a presentation highlighting the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) at the recent Western Trauma Association (WTA) Meeting in Alberta, Canada.
Birmingham AL, March 23, 2023, Compression Works, Inc., a company dedicated to manufacturing hemorrhage control medical devices for military and first responder markets around the world, has partnered with Mission to The World (MTW) and their relief effort at Crates for Ukraine, a humanitarian relief operation to supply life-saving medical supplies to the war-torn region.
Birmingham AL, March 7, 2023, Compression Works, Inc. manufacturer of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, announces a new 510(k) clearance from the FDA. This is the third 510(k) clearance granted by the U.S. Food and Drug Administration (FDA) for the AAJT-S technology.
Birmingham AL, February 28, 2023 - Compression Works, Inc., a medical device company and manufacturer of the Abdominal Aortic & Junctional Tourniquet – Stabilized (AAJT-S) for the treatment of non-compressible hemorrhages in the global EMS and Military markets, announced they had named Bob Huebner as the company’s new National Director of Training.
Birmingham AL, July 14, 2022, Compression Works Inc., the medical device company that created the Abdominal Aortic and Junctional Tourniquet – Stabilized (AAJT-S) for the treatment of non-compressible hemorrhages in the global EMS and military markets, welcomes Scott Garrett as its new Chief Operating Officer.
Dallas TX, May 18, 2022, Compression Works is in the middle of raising a $2 million convertible note, of which Dodson said it has closed about 75%. With the new funding, the company will be bringing on new team members to expand its production capabilities and find new clients in the field.
Birmingham AL, May 03, 2022, Compression Works, creators of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, announces the publication of a new trauma review article in the Annals of Emergency Medicine, “External Aortic Compression in Noncompressible Truncal Hemorrhage and Traumatic Cardiac Arrest: A Scoping Review.” The study examines aortic compression as it relates to non-compressible truncal hemorrhage and traumatic cardiac arrest subjects.
Birmingham AL, April 04, 2022, Compression Works, Inc. maker of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, announces a relief effort to support the people of Ukraine with its life-saving hemorrhage control solution. The AAJT-S devices are intended to help warfighters and civilians who have been injured as a result of the Russia invasion.
Birmingham AL, December 20, 2021, Compression Works, creators of the life-saving Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) device, has dramatically increased their pre-hospital EMS distribution capabilities across the United States.
The AAJT-S is cleared by the FDA, CE marked for sale outside of the U.S., meets the CoTCCC criteria, and has been vetted, studied and published by the Institute for Surgical Research (ISR) and the 59th Med Wing of the U.S. Air Force researchers in San Antonio, Texas. The Compression Works device is also featured in over 64 peer reviewed publications in the literature.
The Abdominal Aortic and Junctional Tourniquet–Stabilized (AAJT-S) that treats both pelvic hemorrhage and severe bilateral lower junctional hemorrhage has been approved for use by paramedics and other first-responders in Alabama.
Tactical medics worldwide use the Abdominal Aortic and Junctional Tourniquet–Stabilized (AAJT-S) to control hemorrhage from armpit, groin and pelvic injuries.
The AAJT-S continues to be the only junctional and true truncal tourniquet to have saved life in upper and lower junctional hemorrhage.
Noncompressible torso hemorrhage is recognized as the leading cause of death in trauma, but definitive hemorrhage control has been challenging.
Croushorn’s fanny pack-like tourniquet (which won a 2012 Popular Science invention award) received FDA approval in 2011 and saved its first two lives this summer.
